Steffen Massberg

Title: Steffen Massberg: Innovator in Immunoadhesin Technology

Introduction

Steffen Massberg is a notable inventor based in Munich, Germany. He has made significant contributions to the field of immunology through his innovative work on immunoadhesins. With a total of two patents to his name, Massberg is recognized for his advancements in fusion protein technology.

Latest Patents

Massberg's latest patents include groundbreaking inventions related to immunoadhesins. The first patent describes an immunoadhesin comprising a glycoprotein VI domain. This invention provides a fusion protein that includes the extracellular domain of glycoprotein VI, which is functional for binding to collagen, along with the Fc domain of an immunoglobulin. The fusion protein is characterized by a specific polypeptide chain and is obtainable through a process that yields the protein in the form of a specific dimer. The second patent focuses on polynucleotides encoding similar immunoadhesins, further emphasizing the importance of glycoprotein VI in therapeutic applications.

Career Highlights

Steffen Massberg is currently associated with Trigen GmbH, where he continues to develop innovative solutions in the field of immunology. His work has garnered attention for its potential applications in medical treatments and therapies.

Collaborations

Massberg collaborates with esteemed colleagues such as Meinrad Gawaz and Andreas Bültmann. Their combined expertise contributes to the advancement of research and development in their field.

Conclusion

Steffen Massberg's contributions to immunoadhesin technology highlight his role as a leading inventor in the field. His patents reflect a commitment to innovation and the potential for significant advancements in medical science.